Navigation Links
Eastern Clinical Trials Russia-CEE Joins BIOCOM CRO
Date:5/1/2013

Moscow, Russia (PRWEB) May 01, 2013

Eastern Clinical Trials (ECT), a contract research organization (CRO) with operations in Russia, Central and Eastern Europe, is pleased to announce that ECT has joined BIOCOM CRO. BIOCOM CRO is a newly created Initiative by BIOCOM (San Diego) the largest regional life science association in the world.     "We are proud to become a member of BIOCOM CRO, a network consisting of the most reputable Life Science Companies and CROs in the Southern California region", said Dr. Svetlana Vodolazhskaya, ECT's Managing Director. "We look forward to being actively involved in the strategy and direction of the rapidly expanding Clinical Research outsourcing community in connecting clinical research programs on a global basis".

Representing Eastern Clinical Trials on BIOCOM CRO advisory committee is Jack Florio, ECT’s representative in the San Diego office. Jack can be reached at jack(dot)florio(at)easterntrials(dot)com
or +1 (858) 864-4339.

About Eastern Clinical Trials (ECT http://www.easterntrials.com)
Established in 2004, Eastern Clinical Trials (ECT) has grown from a local Moscow-based CRO to a trusted regional partner in clinical research with operations in Russia, Ukraine, Belarus, Georgia, Hungary and Slovakia. ECT provides a full spectrum of clinical trial services including project management, monitoring, study feasibility, regulatory submission and support, translation, safety reporting and warehousing.

About BIOCOM CRO (http://www.biocomcro.org )
BIOCOM CRO is an initiative created by BIOCOM, the world’s largest life science association with 550 members in the Southern California region.

ECT Contact:
Svetlana Vodolazhskaya, MD
Managing Director
Russia 119034 Moscow
Tel: + 7(925)5023189
svetlana(dot)vodolazhskaya(at)easterntrials(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10681667.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Reminder: Spherix to Hold Business Update Conference Call April 11 at 1:00 p.m. Eastern Time
2. Northeastern University Nanomanufacturing Center Director Ahmed Busnaina to Present Webinar on “The Democratization of Manufacturing”
3. Eastern Clinical Trials Russia CRO Passes EMA Inspection
4. Aviir Signs Distribution and Expansion Pact Covering 19 Middle Eastern and North African Countries
5. Aviir Signs Distribution And Expansion Pact Covering 19 Middle Eastern And North African Countries
6. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
7. Positive Clinical Study Results for BSPs HyperQ Technology
8. DermTechs Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study
9. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
10. AtheroNova Inc. Preclinical Study Demonstrates 95% Reduction in Arterial Plaque Formation
11. A New Type of Dendritic Cell-Based Cancer Vaccine has Received Approval for Clinical Tests and at the Same Time Secures Substantial Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... 23, 2017 In today,s pre-market ... in the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), ... MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." ... report at: ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: ... Genetics Center (RGC), U.K. Biobank and GSK to generate genetic ... Biobank resource. The initiative will enable researchers to gain valuable ... for a wide range of serious and life threatening diseases. ... Genetic ...
(Date:3/22/2017)... COPENHAGEN, Denmark , March 22, 2017 /PRNewswire/ ... that utilizes its innovative TransCon technology to address ... announced financial results for the full year ended ... a significant year for our company as we ... become a leading, integrated rare disease company with ...
(Date:3/22/2017)... Mass. , March 22, 2017 Good ... that it has eclipsed the 130 million covered lives ... Blue Shield of Texas . With ... the Company continues to enjoy strong payor acceptance based ... its clinical programs and genetic counseling, its industry-leading customer ...
Breaking Biology Technology:
(Date:3/2/2017)... Australian stem cell and regenerative medicine company, ... an agreement with the Monash Lung Biology Network, a ... and Department of Pharmacology at Monash University, ... to support the use of Cymerus™ mesenchymal stem cells ... Asthma is a chronic, long term lung condition recognised ...
(Date:2/28/2017)... BARCELONA , Spanien, 27. Februar 2017 /PRNewswire/ ... durch Iris-Scan, wird seine erstklassige biometrische Lösung ... Snapdragon™ 835 mit X16 LTE auf dem ... 2. März) am Qualcomm-Stand in Halle 3, ... 835-Prozessor beinhaltet die Sicherheitsplattform Qualcomm Haven™ – ...
(Date:2/22/2017)... , Feb. 22, 2017 With the ... ABI Research identifies four technologies that innovative and ... secure significant share in the changing competitive landscape: ... passive authentication.   "Companies can no ... to security," says Dimitrios Pavlakis , Industry ...
Breaking Biology News(10 mins):